Cannabix Technologies Inc. (BLO.CN)
CAD 0.35
(-1.41%)
CAD 0.35
(-1.41%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 248.02 Thousand CAD | 4.58% |
| 2022 | 237.16 Thousand CAD | 96.27% |
| 2021 | 120.83 Thousand CAD | 49.6% |
| 2020 | 80.77 Thousand CAD | -12.41% |
| 2019 | 92.22 Thousand CAD | -56.78% |
| 2018 | 213.36 Thousand CAD | 14.27% |
| 2017 | 186.71 Thousand CAD | 17.84% |
| 2016 | 158.45 Thousand CAD | 2895.39% |
| 2015 | 5290.00 CAD | -92.4% |
| 2014 | 69.59 Thousand CAD | -14.81% |
| 2013 | 81.69 Thousand CAD | 131.74% |
| 2012 | 35.25 Thousand CAD | 1858.39% |
| 2011 | 1800.00 CAD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 214.68 Thousand CAD | -13.44% |
| 2023 Q1 | 219.64 Thousand CAD | -7.39% |
| 2023 Q4 | 248.02 Thousand CAD | 131.75% |
| 2023 FY | 248.02 Thousand CAD | 4.58% |
| 2023 Q3 | 107.02 Thousand CAD | -44.84% |
| 2023 Q2 | 194.01 Thousand CAD | -11.67% |
| 2022 Q1 | 149.35 Thousand CAD | 23.6% |
| 2022 FY | 237.16 Thousand CAD | 96.27% |
| 2022 Q4 | 237.16 Thousand CAD | 71.33% |
| 2022 Q2 | 125.76 Thousand CAD | -15.8% |
| 2022 Q3 | 138.42 Thousand CAD | 10.07% |
| 2021 Q2 | 109.63 Thousand CAD | 7.09% |
| 2021 Q4 | 120.83 Thousand CAD | 19.69% |
| 2021 Q1 | 102.38 Thousand CAD | 26.75% |
| 2021 Q3 | 100.95 Thousand CAD | -7.92% |
| 2021 FY | 120.83 Thousand CAD | 49.6% |
| 2020 Q3 | 92.79 Thousand CAD | -2.42% |
| 2020 Q2 | 95.09 Thousand CAD | 49.53% |
| 2020 Q1 | 63.59 Thousand CAD | -31.04% |
| 2020 FY | 80.77 Thousand CAD | -12.41% |
| 2020 Q4 | 80.77 Thousand CAD | -12.95% |
| 2019 FY | 92.22 Thousand CAD | -56.78% |
| 2019 Q3 | 78.53 Thousand CAD | 25.57% |
| 2019 Q4 | 92.22 Thousand CAD | 17.42% |
| 2019 Q2 | 62.54 Thousand CAD | -28.38% |
| 2019 Q1 | 87.32 Thousand CAD | -59.07% |
| 2018 Q1 | 76.03 Thousand CAD | -59.28% |
| 2018 FY | 213.36 Thousand CAD | 14.27% |
| 2018 Q4 | 213.36 Thousand CAD | 110.44% |
| 2018 Q3 | 101.39 Thousand CAD | 83.45% |
| 2018 Q2 | 55.26 Thousand CAD | -27.31% |
| 2017 Q2 | 47.11 Thousand CAD | -55.31% |
| 2017 FY | 186.71 Thousand CAD | 17.84% |
| 2017 Q4 | 186.71 Thousand CAD | 247.0% |
| 2017 Q3 | 53.8 Thousand CAD | 14.22% |
| 2017 Q1 | 105.41 Thousand CAD | -33.47% |
| 2016 Q2 | 89.43 Thousand CAD | 64.38% |
| 2016 Q3 | 37.58 Thousand CAD | -57.97% |
| 2016 Q4 | 158.45 Thousand CAD | 321.58% |
| 2016 FY | 158.45 Thousand CAD | 2895.39% |
| 2016 Q1 | 54.4 Thousand CAD | 928.45% |
| 2015 Q4 | 5290.00 CAD | -84.37% |
| 2015 Q3 | 33.85 Thousand CAD | -9.89% |
| 2015 Q2 | 37.56 Thousand CAD | 5.96% |
| 2015 Q1 | 35.45 Thousand CAD | -49.05% |
| 2015 FY | 5290.00 CAD | -92.4% |
| 2014 Q1 | 84.02 Thousand CAD | 2.86% |
| 2014 FY | 69.59 Thousand CAD | -14.81% |
| 2014 Q3 | 110.29 Thousand CAD | 12.83% |
| 2014 Q4 | 69.59 Thousand CAD | -36.9% |
| 2014 Q2 | 97.74 Thousand CAD | 16.33% |
| 2013 FY | 81.69 Thousand CAD | 131.74% |
| 2013 Q2 | 117.49 Thousand CAD | 124.8% |
| 2013 Q3 | 89.49 Thousand CAD | -23.83% |
| 2013 Q4 | 81.69 Thousand CAD | -8.72% |
| 2013 Q1 | 52.26 Thousand CAD | 48.27% |
| 2012 Q4 | 35.25 Thousand CAD | 222107.51% |
| 2012 Q3 | 15.86 CAD | 0.0% |
| 2012 FY | 35.25 Thousand CAD | 1858.39% |
| 2011 FY | 1800.00 CAD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Aquarius Surgical Technologies Inc. | 5.17 Million CAD | 95.212% |
| Predictmedix Inc. | 625.14 Thousand CAD | 60.326% |